Emergency remote teaching in process simulation using DWSIM: a case study from DIQ-UMAG, Chilean Patagonia / Enseñanza remota de emergencia en simulación de procesos con DWSIM: un caso estudio DIQ-UMAG, Patagonia Chilena

Due to the worldwide COVID-19 pandemic, Chilean universities were forced to transition from face-to-face classes to online instruction. In response, the Department of Chemical Engineering (DIQ) at the University of Magallanes sought alternative strategies for remote teaching. This article reports on their experience of delivering technical process simulation skills to their final-year undergraduate chemical engineering students. Due to difficulties connecting with the commercial software Aspen HYSYS, which was housed at the university, the department turned to the open-source software, DWSIM, as an alternative. The material content was adapted, and video tutorials were created to meet learning objectives. The software was taught in a new module within the Project Engineering course to develop the skills needed for students to design and simulate a chemical plant. Positive feedback and constructive criticism were received from the students through anonymous surveys and discussion forums. In response, DIQ launched its YouTube channel, DIQ_DWSIM, which has had a positive impact on Spanish-speaking individuals seeking to learn DWSIM. Additionally, two universities have used the channel as support material for their process simulation courses. A second survey of the YouTube audience has further solidified the value of this open online educational resource for higher education learning

Higgs-Boson Production Induced by Bottom Quarks

Bottom quark-induced processes are responsible for a large fraction of the LHC discovery potential, in particular for supersymmetric Higgs bosons. Recently, the discrepancy between exclusive and inclusive Higgs boson production rates has been linked to the choice of an appropriate bottom factorization scale. We investigate the process kinematics at hadron colliders and show that it leads to a considerable decrease in the bottom factorization scale. This effect is the missing piece needed to understand the corresponding higher order results. Our results hold generally for charged and for neutral Higgs boson production at the LHC as well as at the Tevatron. The situation is different for single top quark production, where we find no sizeable suppression of the factorization scale. Turning the argument around, we can specify how large the collinear logarithms are, which can be resummed using the bottom parton picture.Comment: 18 page

Final analysis from RESONATE: Up to six years of follow‐up on ibrutinib in patients with previously treated chronic lymphocytic leukemia or small lymphocytic lymphoma

Ibrutinib, a once‐daily oral inhibitor of Bruton's tyrosine kinase, is approved in the United States and Europe for treatment of patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL). The phase 3 RESONATE study showed improved efficacy of single‐agent ibrutinib over ofatumumab in patients with relapsed/refractory CLL/SLL, including those with high‐risk features. Here we report the final analysis from RESONATE with median follow‐up on study of 65.3 months (range, 0.3‐71.6) in the ibrutinib arm. Median progression‐free survival (PFS) remained significantly longer for patients randomized to ibrutinib vs ofatumumab (44.1 vs 8.1 months; hazard ratio [HR]: 0.148; 95% confidence interval [CI]: 0.113‐0.196; P˂.001). The PFS benefit with ibrutinib vs ofatumumab was preserved in the genomic high‐risk population with del(17p), TP53 mutation, del(11q), and/or unmutated IGHV status (median PFS 44.1 vs 8.0 months; HR: 0.110; 95% CI: 0.080‐0.152), which represented 82% of patients. Overall response rate with ibrutinib was 91% (complete response/complete response with incomplete bone marrow recovery, 11%). Overall survival, censored for crossover, was better with ibrutinib than ofatumumab (HR: 0.639; 95% CI: 0.418‐0.975). With up to 71 months (median 41 months) of ibrutinib therapy, the safety profile remained consistent with prior reports; cumulatively, all‐grade (grade ≥3) hypertension and atrial fibrillation occurred in 21% (9%) and 12% (6%) of patients, respectively. Only 16% discontinued ibrutinib because of adverse events (AEs). These long‐term results confirm the robust efficacy of ibrutinib in relapsed/refractory CLL/SLL irrespective of high‐risk clinical or genomic features, with no unexpected AEs. This trial is registered at www.clinicaltrials.gov (NCT01578707)

Charged Higgs Boson Production in Bottom-Gluon Fusion

We compute the complete next-to-leading order SUSY-QCD corrections for the associated production of a charged Higgs boson with a top quark via bottom-gluon fusion. We investigate the applicability of the bottom parton description in detail. The higher order corrections can be split into real and virtual corrections for a general two Higgs doublet model and into additional massive supersymmetric loop contributions. We find that the perturbative behavior is well under control. The supersymmetric contributions consist of the universal bottom Yukawa coupling corrections and non-factorizable diagrams. Over most of the relevant supersymmetric parameter space the Yukawa coupling corrections are sizeable, while the remaining supersymmetric loop contributions are negligible.Comment: 18 pages, v2: some discussions added, v3: published versio

Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990-2015: A systematic analysis for the Global Burden of Disease Study 2015

Background: The Global Burden of Diseases, Injuries, and Risk Factors Study 2015 provides an up-to-date synthesis of the evidence for risk factor exposure and the attributable burden of disease. By providing national and subnational assessments spanning the past 25 years, this study can inform debates on the importance of addressing risks in context. Methods: We used the comparative risk assessment framework developed for previous iterations of the Global Burden of Disease Study to estimate attributable deaths, disability-adjusted life-years (DALYs), and trends in exposure by age group, sex, year, and geography for 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks from 1990 to 2015. This study included 388 risk-outcome pairs that met World Cancer Research Fund-defined criteria for convincing or probable evidence. We extracted relative risk and exposure estimates from randomised controlled trials, cohorts, pooled cohorts, household surveys, census data, satellite data, and other sources. We used statistical models to pool data, adjust for bias, and incorporate covariates. We developed a metric that allows comparisons of exposure across risk factors—the summary exposure value. Using the counterfactual scenario of theoretical minimum risk level, we estimated the portion of deaths and DALYs that could be attributed to a given risk. We decomposed trends in attributable burden into contributions from population growth, population age structure, risk exposure, and risk-deleted cause-specific DALY rates. We characterised risk exposure in relation to a Socio-demographic Index (SDI). Findings: Between 1990 and 2015, global exposure to unsafe sanitation, household air pollution, childhood underweight, childhood stunting, and smoking each decreased by more than 25%. Global exposure for several occupational risks, high body-mass index (BMI), and drug use increased by more than 25% over the same period. All risks jointly evaluated in 2015 accounted for 57·8% (95% CI 56·6–58·8) of global deaths and 41·2% (39·8–42·8) of DALYs. In 2015, the ten largest contributors to global DALYs among Level 3 risks were high systolic blood pressure (211·8 million [192·7 million to 231·1 million] global DALYs), smoking (148·6 million [134·2 million to 163·1 million]), high fasting plasma glucose (143·1 million [125·1 million to 163·5 million]), high BMI (120·1 million [83·8 million to 158·4 million]), childhood undernutrition (113·3 million [103·9 million to 123·4 million]), ambient particulate matter (103·1 million [90·8 million to 115·1 million]), high total cholesterol (88·7 million [74·6 million to 105·7 million]), household air pollution (85·6 million [66·7 million to 106·1 million]), alcohol use (85·0 million [77·2 million to 93·0 million]), and diets high in sodium (83·0 million [49·3 million to 127·5 million]). From 1990 to 2015, attributable DALYs declined for micronutrient deficiencies, childhood undernutrition, unsafe sanitation and water, and household air pollution; reductions in risk-deleted DALY rates rather than reductions in exposure drove these declines. Rising exposure contributed to notable increases in attributable DALYs from high BMI, high fasting plasma glucose, occupational carcinogens, and drug use. Environmental risks and childhood undernutrition declined steadily with SDI; low physical activity, high BMI, and high fasting plasma glucose increased with SDI. In 119 countries, metabolic risks, such as high BMI and fasting plasma glucose, contributed the most attributable DALYs in 2015. Regionally, smoking still ranked among the leading five risk factors for attributable DALYs in 109 countries; childhood underweight and unsafe sex remained primary drivers of early death and disability in much of sub-Saharan Africa. Interpretation: Declines in some key environmental risks have contributed to declines in critical infectious diseases. Some risks appear to be invariant to SDI. Increasing risks, including high BMI, high fasting plasma glucose, drug use, and some occupational exposures, contribute to rising burden from some conditions, but also provide opportunities for intervention. Some highly preventable risks, such as smoking, remain major causes of attributable DALYs, even as exposure is declining. Public policy makers need to pay attention to the risks that are increasingly major contributors to global burden. Funding: Bill & Melinda Gates Foundation

Quantificação de fatores de crescimento na pele de equinos tratada com plasma rico em plaquetas

O plasma rico em plaquetas (PRP) é um produto derivado da centrifugação do sangue total, sendo rico em fatores bioativos, como os de crescimento. Apesar da ampla utilização em processos cicatriciais, há controvérsia sobre a eficácia da terapia na cicatrização cutânea. O objetivo desse estudo foi quantificar e comparar a concentração dos fatores TGF-β1 e PDGF-BB no PRP, plasma sanguíneo e pele, durante diferentes fases do processo de cicatrização da pele tratada ou não com PRP. Foram utilizados sete equinos machos castrados, mestiços, hígidos, com idade entre 16 e 17 (16,14±0,63) anos. Três lesões em formato quadrangular (6,25cm²) foram produzidas cirurgicamente nas regiões glúteas direita e esquerda de todos os animais. Doze horas após indução das feridas, 0,5mL do PRP foi administrado em cada uma das quatro extremidades das feridas de uma das regiões glúteas (Grupo tratado = GT), escolhida aleatoriamente. A região contralateral foi utilizada como controle (GC). As feridas foram submetidas à limpeza diária com água Milli Q, e amostras foram obtidas mediante biópsias realizadas com Punch de 6mm. Foram obtidas seis biópsias de pele, sendo a primeira realizada logo após a produção da ferida (T0), e as demais com 1 (T1) 2 (T2) 7 (T3) e 14 (T4) dias após a indução da lesão. A sexta biópsia (T5) foi obtida após completo fechamento da pele, que ocorreu aproximadamente aos 37 dias (36,85±7,45, GC; 38,85±6,46, GT). Também foram obtidas amostras de sangue com EDTA em todos os tempos mencionados. A quantificação dos fatores de crescimento TGF-β1 e PDGF-BB na pele, PRP e plasma sanguíneo foi realizada pela técnica ELISA. Os dados foram analisados estatisticamente pelo teste t, correlação de Pearson e regressão, utilizando nível de significância de 5%. Não houve diferença entre os grupos, nos valores dos dois fatores de crescimento mensurados na pele, nos diferentes tempos. Também não houve correlação entre a quantidade dos fatores de crescimento presentes na pele e no plasma. Por outro lado, correlação positiva foi observada entre PRP e pele no grupo tratado, para os fatores de crescimento TGF-β1 (r=0,31) e PDGF-BB (r=0,38), bem como entre ambos os fatores de crescimento presentes no PRP (r=0,81). Considerando as concentrações dos fatores de crescimento no T0, os maiores valores cutâneos (p<0,05) do TGF-β1, em ambos os grupos, ocorreram nos tempos T3 e T5. Valores mais elevados (p<0,05) do PDGF-BB ocorreram no T4 (GT) e T5 (GC). No plasma não houve alteração nas concentrações desses fatores em relação ao T0, o que sugere que o PRP não acarreta efeito sistêmico, quando os procedimentos adotados na presente pesquisa são utilizados. A administração local de PRP no volume estudado, 12 h após indução cirúrgica de ferida cutânea na região glútea de equinos não ocasiona maiores concentrações dos fatores de crescimento TGF-β1 e PDGF-BB no plasma sanguíneo e pele, durante o processo de cicatrização

Photon asymmetry measurements of γ→ p→ π0p for Eγ= 320-650 MeV

High-statistics measurements of the photon asymmetry Σ for the γ→ p→ π0p reaction have been made in the center-of-mass energy range W= 1214 - 1450 MeV. The data were measured with the MAMI A2 real photon beam and Crystal Ball/TAPS detector systems in Mainz, Germany. The results significantly improve the existing world data and are shown to be in good agreement with previous measurements, and with the MAID, SAID, and Bonn-Gatchina predictions. We have also combined the photon asymmetry results with recent cross-section measurements from Mainz to calculate the profile functions, Σˇ (= σ0Σ) , and perform a moment analysis. Comparison with calculations from the Bonn-Gatchina model shows that the precision of the data is good enough to further constrain the higher partial waves, and there is an indication of interference between the very small F-waves and the N(1520) 3 / 2 - and N(1535) 1 / 2 - resonances

Estimación de mortalidad natural e incertidumbre para congrio dorado (Genypterus blacodes Schneider, 1801) en la zona sur-austral de Chile Estimation of natural mortality and uncertainty in pink cusk-eel (Genypterus blacodes Schneider, 1801) in southern Chile

El congrio dorado (Genypterus blacodes) es un pez demersal de gran importancia económica en la pesquería multiespecífica y multiflota que opera en la zona sur-austral de Chile (41°28'-57°00'S). Desde principio de los años noventas se consideró para efectos de la evaluación poblacional la existencia de un único stock. Sin embargo, varios antecedentes relacionados con la historia de vida y demografía han conducido a que, desde el año 2005, la evaluación de esta especie se realice bajo dos stocks administrativos, uno en la zona norte (41°28'-47°00'S) y otro en la zona sur (47°00'-57°00'S). La separación de stocks produce una demanda por actualización de parámetros de historia de vida, entre éstos la mortalidad natural (M). En este trabajo se estimó M para el congrio dorado mediante métodos empíricos aplicados por zona y sexo. La incertidumbre en M fue incorporada a través de remuestreo de Monte Carlo considerando dos fuentes de error, una proveniente de los parámetros de historia de vida que alimentan los modelos empíricos y otra, proveniente de los coeficientes que los definen. El promedio de M mediante los diferentes métodos mostró, para una determinada zona, importantes diferencias entre sexos, como también para sexos conjuntos entre zonas de pesca. Los individuos de la zona norte presentaron mayor M que aquellos provenientes de la zona sur y los coeficientes de variación por método son altamente dependientes del tipo de error incorporado. El método de Pauly (1980) parece ser el más adecuado para el congrio dorado entregando valores de M para sexos conjuntos de 0,27 año-1 (IC: 0,13-0,47) en la zona norte y 0,23 año-1 (IC: 0,11-0,40) en la zona sur.<br>Pink cusk-eel (Genypterus blacodes) is a demersal fish of high economic importance for the multi-species and multi-fleet fishery operating off far-southern Chile (41°28'-57°00'S). Since the early 1990s, the existence of a single stock was assumed for purposes of stock assessments. However, several attributes related with life history and demography led to the designation, as of 2005, of two administrative stocks of this species, a northern-austral stock stock (41°28'-47°00S) and a southern-austral stock (47°00-57°00S). The division of these stocks has produced a demand for updating life history parameters, including natural mortality (M). In the present work, we used empirical methods to estimate M for pink cusk-eel by zone and sex. The uncertainty in M was incorporated through Monte Carlo resampling considering two sources of error: one from the life history parameters that feed the empirical models and the other from the coefficients that define them. The average M obtained by the different methods showed important differences between sexes for a given zone and between combined sexes between the different fishing zones. The M for individuals from the northern-austral zone was higher than that for those from the southern-austral zone. The coefficients of variation by method were highly dependent on the type of error incorporated. Pauly's (1980) method seems to be the most appropriate for pink cuskeel, providing M values for the combined sexes of 0.27 year-1 (IC: 0.130.47) for the northern-austral zone and 0.23 year-1 (IC: 0.11-0.40) for the southern-austral zone